 |
Joele Frank handles Apogee Therapeutics as the clinical stage biotechnology company is acquired by AbbVie in a transaction valued at $10.9B.
Apogee’s pipeline includes drug candidates designed to treat inflammatory and immunological diseases including atopic dermatitis and asthma.
“The acquisition of Apogee further builds on our existing leadership, strengthening our ability to deliver innovative medicines to patients who need better options while also creating significant long-term value for shareholders,” said AbbVie CEO Robert Michael.
He believes AbbVie is "uniquely positioned to rapidly advance these programs and continue to transform the standard of care in inflammatory diseases.”
The acquisition is expected to close during the third quarter.
Joele Frank, Wilkinson Brimmer Katcher partners Andrea Rose and Aura Reinhard along with managing director Greg Klassen and director Carly King represent Apogee.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
